Evidence and decision-making in times of pandemic

  • Iván D. Flórez a. Department of Pediatrics and Child Care, Universidad de Antioquia. Medellín, Colombia. b. Department of Health Research Methods, Evidence and Impact, McMaster University. Hamilton, Canada. https://orcid.org/0000-0002-0751-8932
  • Javier M. Sierra Department of Pediatrics and Child Care, Universidad de Antioquia. Medellín, Colombia. https://orcid.org/0000-0002-4131-0801
  • José Andrés Calvache a. Department of Anesthesiology, Universidad del Cauca. Popayán, Colombia. b. Department of Anesthesiology, Erasmus University Medical Center Rotterdam, The Netherlands. c. Editor-in-Chief Colombian Journal of Anesthesiology. Bogotá, Colombia. http://orcid.org/0000-0001-9421-3717
DOI: https://doi.org/10.5554/22562087.e931
Keywords: Evidence, Decision-making, Pandemic, COVID-19
References How to Cite Downloads

References

Sayare S. He was a science star. Then he promoted a questionable cure for Covid-19. The New York Times Magazine [internet]. 2020 [citado: 2020 jul. 29]. Disponible en: https://www.nytimes.com/2020/05/12/magazine/didier-raoult-hydroxychloroquine.html

Sammuels E, Kelly M. How false hope spread about hydroxychloroquine to treat covid-19 — and the consequences that followed. The Washington Post [internet]. 2020 [citado: 2020 jul. 29]. Disponible en: https://www.washingtonpost.com/politics/2020/04/13/how-false-hope-spread-about-hydroxychloroquine-its-consequences/

Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azitromicin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi: https://doi.org/10.1016/j.ijantimicag.2020.105949

Machiels JD, Bleeker-Rovers CP, Heine R, et al. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks? Int J Antimicrob Agents. 2020;56(1):106056. doi: https://doi.org/10.1016/j.ijantimicag.2020.106056

Evans I, Thornton H, Chalmers I, et al. Testing treatments: Better research for better healthcare. 2nd edition. Londres: Pinter & Martin; 2011.

Lipsitch M. Good science is good science: we need specialists, not sects. Eur J Epidemiol. 2020;35(6):519-22. doi: https://doi.org/10.1007/s10654-020-00651-2

Djulbegovic B, Guyatt G. EBM and the theory of knowledge. En: Guyatt G, Meade M, Cook D, eds. Users' guides to the medical literature: A manual for evidence-based clinical practice. Boston: McGraw-Hill; 2014.

Rutter H, Wolpert M, Greenhalgh T. Managing uncertainty in the covid-19 era. https://blogs.bmj.com/bmj/2020/07/22/managing-uncertainty-in-the-covid-19-era/

Djulbegovic B, Guyatt G. Evidence-based medicine in times of crisis. J Clin Epidemiol. 2020. doi: https://doi.org/10.1016/j.jclinepi.2020.07.002

Kalil AC. Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA. 2020;323(19):1897-8. doi: https://doi.org/10.1001/jama.2020.4742

RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with covid-19 — preliminary report. New Eng J Med. 2020. doi: https://doi.org/10.1056/NEJMoa2021436

Siemieniuk Reed AC, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Pardo-Hernández H, et al. Drug treatments for covid-19: living systematic review and network meta-analysis BMJ. 2020;370:m2980. doi: https://doi.org/10.1136/bmj.m2980

How to Cite
1.
Flórez ID, Sierra JM, Calvache JA. Evidence and decision-making in times of pandemic. Colomb. J. Anesthesiol. [Internet]. 2020Sep.7 [cited 2020Nov.27];48(4). Available from: https://www.revcolanest.com.co/index.php/rca/article/view/931

Downloads

Download data is not yet available.
Published
2020-09-07
How to Cite
1.
Flórez ID, Sierra JM, Calvache JA. Evidence and decision-making in times of pandemic. Colomb. J. Anesthesiol. [Internet]. 2020Sep.7 [cited 2020Nov.27];48(4). Available from: https://www.revcolanest.com.co/index.php/rca/article/view/931
Issue
Vol. 48 No. 4 (2020)
Section
Editorial

Copyright
The Sociedad Colombiana de Anestesiología y Reanimación (S.C.A.R.E.) is the owner of all copyrights to any articles published in the journal. Published manuscripts become the permanent property of S.C.A.R.E. and may not be published elsewhere without written permission. S.C.A.R.E. keeps the right to use these manuscripts in any form, including print, video, audio and digital.

Creative Commons License
Open-access articles can be read, downloaded and shared on a free basis upon publication. The Journal publishes all articles under the CCBY- NC-ND license. Attribution-NonCommercial-NoDerivs: CC BY- NC-ND. Of the six main licenses, this is the most restrictive because it only allows others to download and share articles as long as they give credit to the author, but they cannot in any way change the paper or use it commercially.